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CD81 is found on mouse chromosome 7 among a cluster of 
maternally imprinted genes.24 Imprinting of this gene occurs 
in the placenta, not in the embryo.15,28 The protein is an integral 
membrane protein in the tetraspanin superfamily that serves as 
an adaptor protein.14 The extracellular domain of CD81 interacts 
with cell-surface proteins, and the 3 intracellular domains interact 
with other molecules within the cell.4 CD81 is a required recep-
tor for hepatitis C virus infection34 and originally was identified 
because of its association with CD19 and CD21 molecules in B 
cells.22 CD81 also interacts with the T cell receptor and its core-
ceptors’ components, CD8, CD4, and CD2.17,27 Although much is 
known about how CD81 affects B cell activation and its role as an 
HCV receptor, other specific functions and interactions are not 
well understood.
CD81 has previously been shown to play a role in develop-
ment. Homozygous null female mice develop fertilized embryos 
40% less frequently than do CD81-expressing female mice.26 CD81 
apparently participates in oocyte–sperm fusion, but it has a differ-
ent role than the related tetraspanin molecule, CD9.13,18 CD9 and 
CD81 appear to have complementary roles.26
We established a breeder colony of CD81 knockout mice at our 
institution in 2004 and have maintained records of births and 
development of CD81 offspring over the last 5 y. As expected, 
female CD81null/null mice were infertile. However, examination 
of data for litters sired by CD81null/null male mice revealed unex-
pected skewing of genotypes. We report these data here.
Materials and Methods
All mice were maintained ad libitum on a commercial diet 
(LabDiet 5015, Purina, St Louis, MO) and water. Breeder pairs 
and pups were monitored daily, and survival to weaning was 
greater than 90%. All animal experiments were approved and 
monitored by the Institutional Animal Care and Use Committee 
of Kansas State University.
C.129-Cd81tm1 N7 heterozygotic mice (CD81+/null) were obtained 
from Shoshana Levy (Stanford University, Palo Alto, CA). These 
mice have a targeted disruption in the CD81 gene that was creat-
ed by homologous recombination of a neomycin-resistance gene 
into a segment beginning in the intron between exons 1 and 2 and 
ending in the intron between exons 7 and 8 in strain 129 mice.16 
These mice were backcrossed to BALB/c mice by the Levy group, 
and this line has been maintained by our group since 2004. After 
the initial heterozygote crosses, we bred CD81+/null and CD81null/
null male mice with their CD81+/null female siblings.
C.C3-Tlr4Lpsd/J mice were obtained from The Jackson Labora-
tory (Bar Harbor, ME). These mice have a point mutation located 
within the BB loop of Tlr4 which inhibits the cellular response to 
LPS.23,30 C.C3-Tlr4Lpsd/J mice had been backcrossed more than 20 
generations to the BALB/cJ background.
Mice were genotyped by using tail tissue. For genotyping, 200 
µL lysis reagent (DirectPCR Lysis Reagent, Viagen Biotech, Los 
Angeles, CA) and 0.2 mg/mL proteinase K (Sigma, St Louis, MO) 
were added to each tube containing sample. The tubes were ro-
tated in a hybridization oven (Hybrid National Labnet, Wood-
bridge, NJ) at 55 °C for 6 h (2 × 106 cells) and 18 h (1 mm tail 
tissue). Lysates then were incubated in an 85 °C water bath for 
45 min and stored at 4 °C until DNA was analyzed by PCR. DNA 
sample concentrations were determined spectrophotometrically 
(ND1000 spectrophotometer, NanoDrop Technologies, Wilming-
ton, DE). All samples were diluted to an optimal concentration 
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In our efforts to increase the percentage and number of CD-
81null/null mice born, male CD81null/null mice were used as breeders. 
When CD81+/null female mice crossed with CD81null/null male mice, 
the genotypes of the offspring were not present at the expected 
1:1 ratio of CD81+/null:CD81null/null (P < 0.05; Table 1). Of the 160 
mice examined, 102 were CD81+/null compared with 58 CD81null/null 
mice (that is, approximately 2:1). Although the number of female 
mice born exceeded the number of male mice (93 versus 67), the 
male:female distribution was not significantly (P > 0.10) different 
from the expected 1:1 ratio. In comparison, when CD81+/null mice 
were used as sires, the distribution of homozygotes and heterozy-
gotes did not deviate from expected ratios (Table 1).
Our group is interested in innate immunity, and we have devel-
oped mice with multiple defects in genes thought to contribute to 
innate and acquired immunity.3,11,32 Therefore, we began an effort 
to cross C.C3-Tlr4Lpsd/J and C.129-Cd81tm1 mice. C.C3-Tlr4Lpsd/J 
mice carry a mutation resulting in a proline-to-histidine substi-
tution in the BB region of toll-like receptor 4 (Tlr4). This muta-
tion occurred naturally at the Jackson Laboratories in the 1960s in 
C3H/HeJ mice.29 Another group then backcrossed the defect into 
the BALB/c background.31 Therefore, we had access to a second 
group of breeders that had a breeding history independent of 
those that had been backcrossed to the BALB/c background for 
of 500 to 1000 ng/µL, and a total of 2.5 to 5.0 µg DNA was used 
per reaction. Mice were genotyped by using primers specific for 
sequences in exons 6 and 7 of CD81 (Figure 1). Primers specific 
for the neo gene (Figure 1) were used to confirm targeted disrup-
tion of the CD81 gene. Primers specific for the 14S ribosomal pro-
tein gene25 (Figure 1) were used to assess the quality of the DNA 
sample when neo- or CD81-specific PCR reactions were negative. 
Because of their differences in length, amplicons were run in tan-
dem on ethidium bromide-(Ethidium Bromide Tablets, 10 mg, 
MidSci, St Louis, MO) stained 1.5% agarose (Agarose, Low EEL 
500 GM, Fisher Scientific, Pittsburgh, PA) gels in tandem. cDNA 
was amplified by using GoTaq Flexi DNA Polymerase (Promega, 
Madison, WI) and specific primers (Integrated DNA Technolo-
gies, Coralville, IA; Figure 1).
C.C3-Tlr4Lpsd/J and C.129-Cd81tm1 mice were crossed to gener-
ate mice deficient in both CD81 and Tlr4. F1 mice were brother–
sister-mated to create mice potentially homozygous at both loci. 
Male and female mice for breeding were selected for homozy-
gosity at the Tlr4 gene. Breeding males were either CD81+/null or 
CD81null/null, and breeding females were heterozygous for CD81 
for reasons described above. Tlr4 genotyping was done by using 
methodology that allowed us to distinguish all 3 Tlr4 alleles.32 
cDNA was amplified by using GoTaq Flexi DNA Polymerase 
(Promega) and specific primers (Integrated DNA Technologies; 
Figure 1). Briefly, cDNA underwent restriction enzyme digest to 
reveal restriction fragment length polymorphisms created by the 
C-to-A conversion at nucleotide 39,609 (accession no., AF177767) 
by using Hsp92II (Promega). Digested wild-type Tlr4 cDNA pro-
duced products of 422 and 54 bp. Digested heterozygous Tlr4 
cDNA produced fragments of 422, 320, 102, and 54 base pairs. Di-
gested point-mutated cDNA produced fragments of 320, 102, and 
54 bp. The digested cDNA was resolved on ethidium bromide-
stained, 1.5% agarose gels.
Weight differences were analyzed by paired t test and linear 
regression; genetic data were evaluated by χ2 test (Statmost, De-
taxiom Software, Los Angeles, CA).
Results
We initially used C.129-Cd81tm1 N7 heterozygotic mice to establish 
a CD81-knockout mouse colony and assessed the birth and develop-
ment of CD81+/+,CD81+/null and CD81null/null mice that were born to 
heterozygotic breeding pairs. Nonbreeding mice in our early cohorts 
were weighed approximately every 2 wk over the course of 1 y. For 
each mouse, weight was recorded and plotted against the number 
of weeks since birth. The data from the colony were compiled ac-
cording to genotype (Figure 2). CD81null/null pups grew at the same 
rate as did CD81+/+ and CD81+/null mice, although some female mice 
appeared to lag behind their CD81+/ null and CD81+/+ litter mates in 
weight (Figure 2).
Figure 1. Primers used to identify gene expression by PCR or RT-PCR.
Figure 2. Growth of CD81+/+, CD81null/null, and CD81+/null female (top) 
and male (bottom) mice born to heterozygotic breeding pairs.
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C.C3- Tlr4Lps-d/J × C.129-cd81 tm1 crosses exhibited a similar 2:1 
ratio of heterozygous:homozygous-null births in mice fathered 
by CD81null/null fathers. The C.C3-Tlr4Lpsd/J mice were backcrossed 
into the BALB/c background for 20 generations. Therefore, once 
we made the CD81null/null mice in that cross, those offspring were 
the equivalent of an N8 generation with respect to BALB/c back-
ground.
CD81 is one of several genes in the IC2 region of chromosome 
7 that are maternally imprinted in the placenta but not the em-
bryo.15,28 CD81 appears to act as a growth regulator in brain,6,8,12 
macrophages,19 and other cells.9 Therefore, epigenetic mecha-
nisms may contribute to the skewed genotype distribution. One 
hypothesis to explain the recent evolutionary development of 
imprinting in mammals is that it is a mechanism to control em-
bryonic growth by altering the placenta.1 Ipl is another linked 
gene in the IC2 region that is maternally imprinted.7 Disruption 
of the Ipl gene affects placental size but not the distribution of the 
genotypes born.7 Disruption of the paternal regulatory region of 
IC2 with the KvDMR1 deletion led to the restoration of paternal 
CD81 allelelic expression in the placenta.15 Therefore, the paternal 
allele plays some as-yet-unknown role in the regulatory process. 
Regardless, how the CD81 genotype of the sire affects the geno-
typic distribution of the progeny mice remains unknown. One 
hypothesis is that because CD81 affects cellular growth,6,8,9,12,19 
the absence of CD81 in half of the embryos would alter the fetal– 
maternal balance,10 causing spontaneous abortion of the embryos 
demanding the most resources. This hypothesis is consistent with 
the idea that fetal–placental interactions control fetal growth.1 Ad-
ditional experiments are needed to confirm this hypothesis.
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only 7 generations (C.129-CD81tm1 N7); these mice were selected 
for the Tlr4Lpsd allele. When using C.C3-Tlr4Lpsd/J sires (which 
had been backcrossed for more than 7 generations) that were ho-
mozygous CD81null/null, 42 of the 61 offspring were heterozygous 
at the CD81 gene. This proportion represents, a significant (P < 
0.05) skewing from the expected Mendelian distribution (Table 1). 
Together, our data strongly suggest that male expression of CD81 
may affect genotype distribution among offspring.
Discussion
We discovered that the frequency of successful birth of CD81null/
null mice was about 50% that expected when offspring were sired 
by CD81null/null fathers. This skewed birth distribution has been 
followed by our group for more than 5 y in 36 breeding pairs and 
by using CD81null/null sires bred onto 2 semiindependent BALB/c 
stocks. Although CD81 expression is important for fecundity in 
female mice, male CD81 knockout mice reportedly are fertile,26 
but it was unclear whether the investigators examined the geno-
type distribution from the crosses of those male mice. In addi-
tion, at the time of development of the CD81 knockout mouse, 
CD81-null mice reportedly were born in the expected Mendelian 
ratios and developed without problems.16 However, the parental 
genotypes used in those crosses are unclear.
We found that CD81null/null mice develop similarly to their 
CD81-expressing littermates, regardless of the sire’s genotype. 
Some investigators have suggested that CD81null/null mice with 
a C57BL background do not survive well,12 and we see few neo-
natal fatalities of CD81null/null pups on the BALB/c background. 
Compared with other strains, BALB/c mice are less aggressive 
during pregnancy21 and have lower aggressive responses during 
stress than do C57BL/6 mice.20 These data suggest that provid-
ing that satisfactory husbandry including mouse background are 
present, once mice are born, the CD81 deficiency does not affect 
vital functions or can be complemented by other tetraspanins 
or members of other molecular families.2,5,33 Because the present 
study is semiretrospective, we have yet to determine whether 
CD81null/null embryos are fertilized less successfully than are con-
trols or whether embryos are spontaneously aborted during the 
21-d gestation period of mice.
Because the mice used to establish our breeding colony (C.129-
CD81tm1 N7) had been backcrossed to the BALB/c background 
for only 7 generations, genetic interactions from the mixed 
BALB/c and 129 backgrounds of the knockout16 may have played 
some role in this process. Although we cannot rule out this pos-
sibility, it is unlikely because the genotypes of offspring from our 
Table 1. Effects of parental expression of CD81 on observed offspring genotypes.
Offspring
Parental cross Genotype No. Expected No. Observed P
CD81null/null:Tlr4Lpsd/Lpsd × CD81+/null:Tlr4Lpsd/Lpsd CD81+/null:Tlr4Lpsd/Lpsd 30.5 42
CD81null/null:Tlr4Lpsd/Lpsd 30.5 19 <0.05
CD81+/null:Tlr4Lpsn/Lpsn × CD81+/null:Tlr4Lpsn/Lpsn CD81+/+: Tlr4Lpsn/Lpsn 23.5 26
CD81+/null:Tlr4Lpsd/Lpsd 47 50
CD81null/null:Tlr4Lpsd/Lpsd 23.5 18 not significant
CD81null/null:Tlr4Lpsn/Lpsn × CD81+/null:Tlr4Lpsn/Lpsn CD81+/null:Tlr4Lpsd/Lpsd 80 102
CD81null/null:Tlr4Lpsd/Lpsd 80 58 <0.05
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